Professional Documents
Culture Documents
Evaluation Myelomeningocele Fetal Spine Using Voluson Hdlive Silhouette
Evaluation Myelomeningocele Fetal Spine Using Voluson Hdlive Silhouette
Evaluation Myelomeningocele Fetal Spine Using Voluson Hdlive Silhouette
spine in myelomeningocele.
By Miguel Martínez-Rodríguez, M.D; Rosa Villalobos-Gómez, M.D; Rogelio Cruz-Martínez,
M.D, PhD, Medicina Fetal México, Santiago de Querétaro, Querétaro, México.
gehealthcare.com
Introduction
Open spina bifida is the most common congenital inspection of the spinal vertebrae and searching for
anomaly of the central nervous system (CNS), dorsal defects accompanied with widening of the
associated with long-term neurological handicap. It is transverse processes forming a characteristic V shape;
characterized by protrusion of meninges, spinal cord and this requires longitudinal, transverse and coronal views
nerves through a defect in the overlying vertebral arches of the fetal spine3. Correct characterization of the size
and skin. and content of the defect permit an accurate prognosis
of the postnatal anatomical functional level and optimal
Prenatal diagnosis is usually suspected in the presence surgical planning.
of cranial ultrasound changes including scalloping of the
frontal bones or lemon sign, ventriculomegaly, and In this paper we have the objective to describe how the
posterior fossa obliteration or banana sign. new technological advances in three-dimensional (3-D)
Nevertheless, the best way to diagnose fetal spina bifida ultrasound can be used for clarifying fetal evaluations,
is direct examination of the spine1. as we delineate the acquisition technique of a 3-D
HDlive Silhouette image of the fetal spine for defining
Defining the upper anatomical level of the lesion in the level of the anatomical defect and extension of the
myelomeningocele is one of the main predictors of lesion in fetuses with myelomeningocele.
postnatal neurological morbidity2. This is usually
achieved with two-dimensional (2-D) ultrasound by
Figure 2. Ultrasound 3-D picture with HDlive Silhouette in a sagittal view of the spine, in the
same fetus of Figure 1. The ROI was adjusted to fit all the defect and most of the spinal
column, the profundity and gains have not been adjusted. A divergence between the
posterior arches of the spine is noted to initiate in L2.
Figure 3. Ultrasound 3-D picture with HDlive Silhouette in a sagittal view of the spine, with
the ROI adjusted to fit only the defect, and the principal anatomical landmarks of the
spinal defect are visualized. The arrow points the tethered spinal cord, (+) signalizes
the placode, the nerve roots (*) and (**) indicate the dorsal muscles.
Figure 4. Ultrasound 3-D picture with HDlive Silhouette in a sagittal view of the spine, with
adjustment of profundity and gains, which permits visualization of the first costovertebral
articulation (T12) and the divergence of the posterior arches initiating in L2 (*).
Conclusion Clinical Key Points
We describe an easy method for defining the upper • 3-D ultrasound allows the spatial visualization of some
anatomical level and the extension of the lesion in case structures not easily visualized in 2-D ultrasound.
of open spina bifida using last-generation 3-D ultrasound
rendering with HDlive Silhouette. • Volumetric examination reduces dependence on good
fetal posture for acquisition, helping in the case of a
less experienced users.
As a leading global medical technology, diagnostics and digital solutions innovator, GE Healthcare
enables clinicians to make faster, more informed decisions through intelligent devices, data analytics,
applications and services, supported by its Edison intelligence platform. With over 100 years of
healthcare industry experience and around 50,000 employees globally, the company operates at the
center of an ecosystem working toward precision health, digitizing healthcare, helping drive
productivity and improve outcomes for patients, providers, health systems and researchers around the
world.
The products / technologies mentioned in this material may be subject to the regulation of the
government. Your shipment and effective commercialization only may occur after regulatory approval.
The products/technologies could be described with their market names, different from what is
approved in the regulator. The commercialization of it will occur with the product name registered in
the regulator.
JB00559XL